US Steel Issues Weak Q4 Outlook, Joins Novo Nordisk And Other Big Stocks Moving Lower In Friday's Pre-Market Session
US Steel Issues Weak Q4 Outlook, Joins Novo Nordisk And Other Big Stocks Moving Lower In Friday's Pre-Market Session
U.S. Steel shares dipped 6.5% to $29.65 in the pre-market trading session.U.S. stock futures were lower this morning, with the Dow futures falling over 100 points on Friday.
美国股指期货今晨下跌，道琼斯期货在周五跌幅超过100点。
Shares of United States Steel Corporation (NYSE:X) fell sharply in today's pre-market trading after the company issued fourth-quarter adjusted EPS guidance below analyst estimates.
美国钢铁公司（纽交所：X）的股票在今天的美股盘前交易中大幅下跌，因为该公司发布的第四季度调整后的每股收益指引低于分析师的预期。
After the market close on Thursday, U.S. Steel said it expects to report a fourth-quarter adjusted loss of 25 cents to 29 cents per share. Fourth-quarter adjusted EBITDA is expected to come in around $150 million.
在周四市场收盘后，美国钢铁表示预计第四季度调整后每股将亏损25美分到29美分。第四季度调整后的EBITDA预计将达到约15000万美元。
U.S. Steel shares dipped 6.5% to $29.65 in the pre-market trading session.
美国钢铁的股票在美股盘前交易时下跌了6.5%，报29.65美元。
Here are some other stocks moving lower in pre-market trading.
以下是一些在美股盘前交易中也有下跌的其他股票。
- Novo Nordisk A/S (NYSE:NVO) fell 25.8% to $76.80 in pre-market trading. Novo Nordisk said CagriSema demonstrated weight loss in adults with obesity or overweight in the REDEFINE 1 trial.
- Innovative Industrial Properties, Inc. (NYSE:IIPR) dipped 19.1% to $77.10 in pre-market trading after the company reported a default by Pharmacann on its obligations to pay rent for six of its eleven leases in December.
- Mesoblast Limited (NASDAQ:MESO) shares fell 18.1% to $13.72 in pre-market trading. Mesoblast shares jumped over 36% on Thursday after the company announced the FDA approved Ryoncilas the first mesenchymal stromal cell therapy in the United States.
- Quantum Computing Inc. (NASDAQ:QUBT) fell 11.1% to $13.46 in pre-market trading after declining 41% on Thursday.
- Arqit Quantum Inc. (NASDAQ:ARQQ) declined 7.2% to $24.98 in pre-market trading.
- Transportadora de Gas del Sur S.A. (NYSE:TGS) fell 5.4% to $26.01 in pre-market trading.
- 诺和诺德A/S（纽交所：NVO）在美股盘前交易中下跌25.8%，至76.80美元。诺和诺德表示，CagriSema在REDEFINE 1试验中表现出对肥胖或超重成年人的减重效果。
- 创新工业地产公司（纽交所：IIPR）在美股盘前交易中下跌了19.1%，报77.10美元，此前该公司报告称Pharmacann未能履行其在12月份对六个租约的租金支付义务。
- Mesoblast Limited（纳斯达克：MESO）在美股盘前交易中下跌18.1%，至13.72美元。Mesoblast的股价在周四上涨超过36%，此前该公司宣布FDA批准Ryoncil作为美国首个间充质干细胞疗法。
- 量子计算公司（纳斯达克：QUBT）在美股盘前交易中下跌11.1%，降至13.46美元，此前周四下跌了41%。
- Arqit Quantum Inc. (纳斯达克:ARQQ) 在美股盘前交易中下跌了7.2%，至24.98美元。
- 阿根廷南部燃气 S.A. (纽交所:TGS) 在美股盘前交易中下跌了5.4%，至26.01美元。
Now Read This:
现在阅读这个：
- S&P 500, Nasdaq End In Red As Investor Sentiment Declines, Micron Tumbles After Sales Miss: Greed Index In 'Extreme Fear' Zone
- S&P 500、纳斯达克收跌，投资者情绪下降，美光在销售未达预期后暴跌：贪婪指数处于'极度恐惧'区域